Omeprazol Apofri

Omeprazol Apofri is a well-known pharmaceutical product used to treat conditions related to excess stomach acid, such as GERD, gastric ulcers, and Zollinger-Ellison syndrome. The brand 'Apofri' was established in Sweden as a private label initiative to provide high-quality, affordable generic medicines through Swedish pharmacies. It utilizes the Multiple-Unit Pellet System (MUPS) technology to ensure effective drug delivery and gastrointestinal absorption.

Ownership of the Apofri brand has evolved since its inception. While it was originally developed within the Swedish pharmacy market, it is currently a key brand under the Evolan Pharma AB portfolio. Evolan is a Nordic pharmaceutical company based in Sweden that specializes in the development and marketing of complex generic medicines. The manufacturing of Omeprazol Apofri is primarily centered in Sweden and Europe, adhering to strict pharmaceutical standards to serve the Scandinavian healthcare market.